-
effectivehealthcare-admin.ahrq.gov/sites/default/files/assessing-quality.ppt
January 01, 2010 - (II)
Apply one of several available tools that consider
Intention-to-treat analysis
Differential loss … to followup between the compared groups or overall high loss to followup
Conflict of interest
Apply
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_clinician.pdf
November 01, 2016 - issues related to living with diabetes;
b) a structured dietary intervention (related to weight
loss
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_consumer.pdf
November 01, 2016 - possibly blindness
» Nerve damage
» Foot problems, which in severe cases may
lead to amputation (loss
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_consumer-2016.pdf
January 01, 2016 - possibly blindness
» Nerve damage
» Foot problems, which in severe cases may
lead to amputation (loss
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-patients-with-crohns-disease-what-treatments-or-therapies-alone-or-in-conjunction-with-one-another-provide-the-highest-rate-of-disease-management-with-the-lowest-risk-of-long-term-complications-particularly-in-young-wome
November 01, 2017 - understand which treatment options should be used to reduce the risk of further surgeries and complete loss
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/deliberative-methods-facilitation-slides-text.pdf
January 11, 2017 - • What researchers will learn:
o Concerns about loss of patient/doctor authority
o How people
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/does-the-use-of-cytochrome-p450-2c19-cyp2c19-testing-to-predict-response-to-clopidogrel-in-people-1-with-acute-coronary-syndrome-2-who-have-suffered-other-cardiovascular-disease-related-events-eg-ischemic-stroke-symptomatic-
November 01, 2017 - copies (corresponding to intermediate- and poor-metabolizer phenotypes, respectively) of reduced- or loss-of-function
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cognitive-decline_research-protocol.pdf
March 22, 2016 - characterized by a subjective decline in cognition and objective neurological
testing threshold without a loss … cancer, cardiovascular disease, diabetes, delirium, thyroid disorders, chronic kidney
disease, and loss … Studies with longer durations
and followup may experience different rates of mortality and loss to followup … Long-term impact of behavioral weight loss
intervention on cognitive function.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prosthesis_research-protocol.pdf
March 16, 2017 - Objectives for the Systematic Review
An estimated 1.9 million people in the U.S. are living with limb loss … LLP candidates are a heterogeneous group with distinct needs
dependent upon age, etiology of limb loss … Specifically, patients who are in need of LLPs are heterogeneous in terms of etiology
of limb loss, … “Estimating the Prevalence of Limb Loss in the United States: 2005 to 2050.”
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
November 15, 2012 - Symptoms may include respiratory insufficiency,
hearing loss, joint movement restriction,
enlargement … Symptoms
may include short stature, organomegaly, joint
stiffness, hearing loss, progressive cognitive … central
and peripheral nervous system involvement in this
form of the disease, but there is no neuronal loss
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-disposition-comments.pdf
October 01, 2021 - that after
their breast implants were carefully removed, symptoms
such as joint and/or muscle pain, loss … of hair, memory
loss/cognitive problems, chronic fatigue, breast pain,
persistent skin inflammation
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
September 01, 2010 - They mentioned the importance of lifestyle
interventions including diet, exercise, weight loss, and … Weight loss as therapy
22.2%
(2)
44.4%
(4)
33.3%
(3)
Q14. … Weight loss as therapy
50.0%
(6)
16.7%
(2)
33.3%
(4)
Q16. … /therapeutic benefits for many diseases‖
―I like this idea [weight loss as therapy] because of the … I do
not know any evidence from other trials of exercise (which is always confounded by
weight loss
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
January 01, 2015 - This condition leads to moderate or total vision loss over
time. … Weight reductions were also observed—a loss of 2.8 to 3.7
kg (p<0.05) at 24 weeks in all except the … diabetic macular edema (DME) is laser
photocoagulation, and this treatment cannot reverse vision loss … Vision
loss continues to progress in some patients despite treatment.75-77 Additional vision loss is … .75-77
Additional vision loss is also a risk associated with laser photocoagulation.75 Fluocinolone
-
effectivehealthcare-admin.ahrq.gov/products/cognitive-decline/research-protocol
December 01, 2020 - characterized by a subjective decline in cognition and objective neurological testing threshold without a loss … cancer, cardiovascular disease, diabetes, delirium, thyroid disorders, chronic kidney disease, and loss … Studies with longer durations and followup may experience different rates of mortality and loss to followup … Long-term impact of behavioral weight loss intervention on cognitive function.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
January 01, 2012 - Weight loss was
greater in the gastric-bypass group and sleeve-gastrectomy group (-29.4±9.0 kg and … One
clinical expert stated, “Although any weight loss and, therefore, any bariatric procedure may … Several experts noted that subcutaneous
exenatide use would also result in effective weight loss. … ASMBS 2009: gastric banding
achieves sustained weight loss, improvement of
diabetes. … FDA expands use of banding system for weight
loss. [internet]. Silver Spring (MD): U.S.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
August 01, 2013 - Applicability9 was assessed by considering comorbidities
(psychological or related to hearing loss), … factors: length of time to treatment after onset, audiological
factors (degree and type of hearing loss … Of course,
hearing loss also increases markedly with age starting
in the fourth decade, and hearing … loss and tinnitus often
co-occur.3 Nevertheless, tinnitus is a problem not only
for older adults or … for people with clinically significant
hearing loss.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
November 26, 2024 - demographic often uses stimulants for academic or work-related performance
enhancement,4 as well as weight loss … ethnic and sex composition
• Reason for misuse
Enhance academic or work performance
Weight loss
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/patient-centered-medical-home_disposition-comments.pdf
July 03, 2012 - When children are sick
there is school loss and work loss. … This can have both an immediate
negative economic consequence on the family (loss of income, loss
of … job promotion, loss of job) and long term impact on the family
(poor school performance poor job performance … loss of job). … need for outcome
evaluations that are tailored to the population,
noting the importance of school loss
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
May 08, 2013 - Peer Reviewer
#6
Results Page 83, the interaction of nonbreatheable incontinence pads
on low air loss … beds needs to be discussed
The trial on incontinence pads did not evaluate low air loss
beds so we … Categorization of low-air-loss beds as dynamic or static is
somewhat unclear and inconsistent. … Unfortunately the evidence on low-air loss
mattresses or overlays vs. standard hospital beds or other … Methods Given the loss of so many preventive studies, the exec.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-executive-summary.pdf
October 01, 2022 - found consistent evidence of
dose-response effects for two non-severe adverse effects (SOE: Moderate): loss